• Cardiovascular Disease, Influenza, & COVID-19

    Information provided by Quest Diagnostics

    Seasonal influenza (A and B) and COVID-19 have both been linked to cardiovascular complications in otherwise healthy people without preexisting conditions; they pose even greater risks for complications and mortality in people with preexisting cardiovascular disease.1 Although vaccination can mitigate further cardiovascular risk from influenza,2 the same remains to be shown for COVID-19.

    Read this article to be informed about the associations of cardiovascular disease risk and outcomes with seasonal influenza, as well as emerging information on associations with COVID-19. Also discussed is the importance of laboratory testing for recognizing potential cardiovascular effects of these illnesses.

    1. Ganatra S, Dani SS, Shah S, et al. Management of cardiovascular disease during coronavirus disease (COVID-19) pandemic. Trends Cardiovasc Med. 2020;30(6):315-325. doi:10.1016/j.tcm.2020.05.004
    2. Cheng Y, Cao X, Cao Z, et al. Effects of influenza vaccination on the risk of cardiovascular and respiratory diseases and all-cause mortality. Ageing Res Rev. 2020;62:101124. doi:10.1016/j.arr.2020.101124

    About Sponsored Content

    The posting of sponsored information and content on this page should not be considered an AAFP endorsement or recommendation of the sponsor's products, services, policies, or procedures. The information and opinions expressed on this page are those of the paid sponsors and do not necessarily reflect the view of the AAFP. The AAFP is not responsible for the content of third-party websites linked from this page; moreover, any links on this page to third-party websites where goods or services are advertised are not endorsements or recommendations by the AAFP of the third-party sites, goods, or services.